Fiche centre
Mayo Clinic
Rochester — United States
Essais liés51clinical trials
VilleRochesterlocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07868614
Essais cliniques associés
51| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| ExAblate MRgFUS | Cancer | Non applicable | NCT01833806 | A Phase IV Post Approval Clinical Study of ExAblate Treatment of Metastatic Bone Tumors for the Palliation of Pain | COMPLETED |
| Sphere-360 Pulsed Field Ablation Catheter with the Affera Mapping and Ablation System | Maladie coronarienne | Non applicable | NCT07308847 | Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360) | ACTIVE_NOT_RECRUITING |
| Carisbamate | Épilepsie | Phase 3 | NCT05219617 | Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults | RECRUITING |
| BIA 28-6156 10 mg | Parkinson | Phase 2 | NCT05819359 | ACTIVATE — Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD | COMPLETED |
| Allogeneic Hematopoietic Stem Cell Transplantation | SEP | Phase 2 | NCT00104858 | Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | COMPLETED |
| [O-15]-Water PET Myocardial Perfusion Imaging (MPI) | Maladie coronarienne | Phase 3 | NCT05134012 | RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW) | COMPLETED |
| 18F-AV-1451 | Alzheimer | Phase 2 | NCT06723015 | Tau PET Outcomes With Anti-amyloid Immunotherapies | ENROLLING_BY_INVITATION |
| brexucabtagene autoleucel | SEP | Phase 1 | NCT03624036 | ZUMA-8 — Study to Evaluate the Safety and Tolerability of Brexucabtagene Autoleucel (KTE-X19) in People With Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma | TERMINATED |
| anito-cel | Myasthénie | Phase 1 | NCT06626919 | Study of Anitocabtagene Autoleucel in Participants With Non-Oncology Plasma Cell-Related Diseases | RECRUITING |
| Autologous Hematopoietic Stem Cell Transplantation | SEP | Phase 3 | NCT04047628 | Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS) | RECRUITING |
| WiSE System | Insuffisance cardiaque | Non applicable | NCT02922036 | SOLVE-CRT — Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients | ACTIVE_NOT_RECRUITING |
| Colchicine 0.5 MG Oral Tablet | Maladie coronarienne | Phase 3 | NCT04774159 | LEADER-PAD — Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk | RECRUITING |
| Acoramidis | Alzheimer | Phase 2 | NCT03536767 | Open-Label Study of AG10 in Patients With Cardiomyopathy | TERMINATED |
| Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) | SEP | Phase 2 | NCT00166439 | Trial of Oxaliplatin, Cytosine Arabinoside, Dexamethasone With Rituxan (ROAD) in Patients With Relapsed Non-Hodgkins Lymphoma | COMPLETED |
| Multifunctional Apparatus for Voltammetry, Electrophysiology, and Neuromodulation (MAVEN) | Parkinson | À vérifier | NCT07868614 | Intraoperative Microelectrode Recordings Using MAVEN Compared to Standard Recording Apparatuses | RECRUITING |
| Exablate Prostate Treatment | Cancer | Non applicable | NCT03998657 | Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions | ACTIVE_NOT_RECRUITING |
| Irreversible Electroporation | Cancer | Non applicable | NCT04972097 | PRESERVE — Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue | COMPLETED |
| 18F-Flortaucipir radiopharmaceutical | Alzheimer | Phase 1 | NCT05361382 | Head-to-Head Harmonization of Tau Tracers in Alzheimer's Disease | ACTIVE_NOT_RECRUITING |
| Case-Control Study of the Glycotest™ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma | Cancer | À vérifier | NCT03878550 | Case-Control Study of the Glycotest™ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma | ACTIVE_NOT_RECRUITING |
| NC-SUDEP — Neural Circulatory Control and SUDEP Risk. | Épilepsie | À vérifier | NCT02813980 | NC-SUDEP — Neural Circulatory Control and SUDEP Risk. | ACTIVE_NOT_RECRUITING |
| Immunoglobulin | SEP | Phase 3 | NCT00000117 | Intravenous Immunoglobulin Therapy in Optic Neuritis | COMPLETED |
| Radical Prostatectomy | Cancer | Non applicable | NCT05027477 | CAPTAIN — A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer | ACTIVE_NOT_RECRUITING |
| MN-166 | Sclérose latérale amyotrophique | À vérifier | NCT06743776 | SEANOBI-ALS — Scalable Expanded Access With Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS | NO_LONGER_AVAILABLE |
| Antidepressant | Myopathies | Phase 2 | NCT04747314 | TNA-LBP — Treating Negative Affect in Low Back Pain Patients | COMPLETED |
| NanoKnife Procedure | Cancer | Non applicable | NCT01972867 | Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients | UNKNOWN |
| Medtronic Astra/Azure DR MRI IPG with AVIM therapy Activated | Hypertension | Non applicable | NCT06059638 | BACKBEAT — BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT | RECRUITING |
| Anakinra | Épilepsie | Phase 3 | NCT07281027 | COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE" | NOT_YET_RECRUITING |
| PROMOTE — Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy | Cancer | À vérifier | NCT01953640 | PROMOTE — Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy | COMPLETED |
| PROACTION: — Investigations of Reproductive Cancers in Women | Cancer | À vérifier | NCT06527157 | PROACTION: — Investigations of Reproductive Cancers in Women | RECRUITING |
| Brain Interchange System | Épilepsie | Non applicable | NCT05439655 | Acute Recording of Stereotyped High-Frequency Oscillations | ACTIVE_NOT_RECRUITING |
| Solanezumab | Alzheimer | Phase 3 | NCT02008357 | A4 — Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss | COMPLETED |
| GBPDC: Gut-Brain in PD Consortium Master Protocol | Parkinson | À vérifier | NCT07567794 | GBPDC: Gut-Brain in PD Consortium Master Protocol | RECRUITING |
| Ubamatamab | Cancer | Phase 2 | NCT07154290 | A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) | RECRUITING |
| HyperQureTM Renal Denervation (RDN) System: | Hypertension | Non applicable | NCT06526858 | Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension | RECRUITING |
| ETX101 | Épilepsie | Phase 1/2 | NCT05419492 | ENDEAVOR — A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome | RECRUITING |
| TREAT-MS — Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial | SEP | Non applicable | NCT03500328 | TREAT-MS — Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial | ACTIVE_NOT_RECRUITING |
| Inebilizumab | Lupus | Phase 2 | NCT06570798 | A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases | RECRUITING |
| Vonsetamig | Lupus | Phase 1 | NCT06975787 | Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis | RECRUITING |
| Hybrid argon plasma ablation (HAPC) | Cancer | Non applicable | NCT03621319 | BURN — Eradicating Barrett's Esophagus Using Radiofrequency Ablation or a Novel Hybrid Argon Plasma Coagulation Technique | TERMINATED |
| Model BB-613WP | Hypertension | Non applicable | NCT07240831 | PPG ABPM — Accuracy of a Cuffless Photoplethysmography (PPG) Chest-Patch Monitor for 24-hour Ambulatory Blood Pressure Monitoring (ABPM) | RECRUITING |
| ION337 | Épilepsie | Phase 1/2 | NCT07531745 | ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome | RECRUITING |
| zorevunersen | Épilepsie | Phase 3 | NCT06872125 | A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome | ACTIVE_NOT_RECRUITING |
| EEG | Épilepsie | Non applicable | NCT06934356 | Subcortical Arousal in Perceptual Awareness | RECRUITING |
| Brain Interchange System | Épilepsie | Non applicable | NCT06898138 | Acute Stimulation and Modulation of Stereotyped High-Frequency Oscillations | NOT_YET_RECRUITING |
| Fosigotifator | Sclérose latérale amyotrophique | Phase 1 | NCT04948645 | A Phase 1 Study to Investigate the Safety and Pharmacokinetics of Fosigotifator in Patients With Amyotrophic Lateral Sclerosis | TERMINATED |
| MT-1186 | Sclérose latérale amyotrophique | Phase 3 | NCT04569084 | Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS | TERMINATED |
| Rimegepant/BHV3000 | Migraine | Phase 3 | NCT04649242 | Randomized Study in Children and Adolescents With Migraine: Acute Treatment | RECRUITING |
| Atogepant 60 mg | Migraine | Phase 4 | NCT06972056 | Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study | RECRUITING |
| Early Highly Effective Therapies Group | SEP | Phase 4 | NCT03535298 | DELIVER-MS — Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS | ACTIVE_NOT_RECRUITING |
| liposomal doxorubicin | Cancer | Phase 2 | NCT01078441 | Bortezomib, Liposomal Doxorubicin Hydrochloride, Dexamethasone, and Cyclophosphamide in Treating Patients With Multiple Myeloma That Relapsed After Autologous Stem Cell Transplant | TERMINATED |
| nL-CHCHD-001 | Sclérose latérale amyotrophique | Phase 1 | NCT07423494 | Personalized Antisense Oligonucleotide Therapy for A Single Patient With CHCHD10 ALS (nL18576) | NOT_YET_RECRUITING |